16-May-2024 | Facts and Factors
Findings from Facts and Factors report “Hyaluronidase Market Size, Share, Growth Analysis Report By By Type (Animal-Derived Hyaluronidase and Synthetic Hyaluronidase), By Application (Dermatology, Ophthalmology, Oncology, and Others), By End-User (Hospitals and Specialty Clinics), And By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2024 – 2032” states that the global Hyaluronidase Market in 2023 is approximately USD 992.38 million. The market is expected to grow at a CAGR of 7.84% and is anticipated to reach around USD 1,957.82 million by 2032.
Proteins designed genetically are called Hyaluronidase. Hyaluronidase is injected into the body to treat dehydration, muscle stiffness and various other health issues. Sometimes these are injected in the body to aid absorption of other injected fluids in a body. Hyaluronidase is employed for a medical practice to upsurge tissue absorption of numerous drugs. These enzymes have been extensively used as spreading agents, along with local anesthetics, chemotherapeutics, and contrast media.
Browse the full “Hyaluronidase Market Size, Share, Growth Analysis Report By By Type (Animal-Derived Hyaluronidase and Synthetic Hyaluronidase), By Application (Dermatology, Ophthalmology, Oncology, and Others), By End-User (Hospitals and Specialty Clinics), And By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2024 – 2032" report at https://www.fnfresearch.com/hyaluronidase-market
Awareness of cosmetic surgery has increased globally, Hyaluronidase is one of the primary enzyme used in cosmetic surgery. This is expected to propel the growth of the Hyaluronidase market around the globe. The demand for Hyaluronidase is increasing with raising skin disorders among various age groups. In addition, various government organizations have made medical and health-related insurances, reimbursement and schemes for aesthetic nonsurgical processes this makes the medical treatment affordable to a large population. This is expected to upsurge the demand for Hyaluronidase across the map.
Overdosage of Hyaluronidasemay cause side effects that can cause harmful disorders. Globally the awareness for side effects is increasing, to curb such harmful disorders; manufacturers are offering medically advanced Hyaluronidase. This factor is expected to create lucrative opportunities for key manufacturers operating in the Hyaluronidase market. Additionally, Hyaluronidase has a wide application area apart from cosmetic surgeries Hyaluronidase is also used to aid contrast dyes to make X-rays more clear and vivid. Owing to wide application areas of Hyaluronidase (SCR) the market is expected to drive demand. Furthermore, the market is experiencing several mergers and acquisitions among top companies across the map to expand their global presence in the Hyaluronidase market.
Manufacturers operating in this market are focused on improving Hyaluronidase performance by introducing safe surgery procedures. This is anticipated to boost demand for the Hyaluronidase market globally.
By product type, the market is divided into Animal-derived Hyaluronidase and Synthetic Hyaluronidase. The Animal-derivedHyaluronidase segment accounted for the largest market share of 66% in the year 2019. Animal-derivedHyaluronidase is expected to aid absorption of other injected fluids in the body, this makes the treatment process less risky. Owing to such factors Animal-derivedHyaluronidase is expected to gain demand during the forecast period. Furthermore, based on the application the market is classified into dermatology, chemotherapy, ophthalmology, plastic surgery and others. Dermatology led the segment in 2019 contributing to 42% of the total market share.
Geographically, the global Hyaluronidase market was dominated by North America by generating revenues worth USD 255.53 Mn in 2019. This dominance is majorly attributed to the rising demand for cosmetic surgery in countries such as the U.S. and Canada. Furthermore, Europe is set to observe the second-fastest growth of a market share of 28% over the forecast period.
Report Scope
| Report Attribute |
Details |
| Market Size in 2023 |
USD 992.38 Million |
| Projected Market Size in 2032 |
USD 1,957.82 Million |
| CAGR Growth Rate |
7.84% CAGR |
| Base Year |
2023 |
| Forecast Years |
2024-2032 |
| Key Market Players |
Amphastar Pharmaceuticals Inc., Bausch & Lomb Incorporated, CBC Pharma, Genomic Solutions, Halozyme Inc., PrimaPharma Inc., Shreya Life Sciences Pvt. Ltd., STEMCELL Technologies Inc., Sun Pharmaceutical Industries Ltd., The Cooper Companies Inc., The Cooper Companies Inc., Valeant Pharmaceuticals, and Others. |
| Key Segment |
By Type, By Application, By End-User, and By Region |
| Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the leading players in the global market include
; Amphastar Pharmaceuticals, Inc., Bausch & Lomb Incorporated, CBC Pharma, Genomic Solutions, Halozyme, Inc., PrimaPharma, Inc., Shreya Life Sciences Pvt. Ltd., STEMCELL Technologies Inc., Sun Pharmaceutical Industries Ltd., The Cooper Companies Inc., The Cooper Companies, Inc., Valeant Pharmaceuticals, and others.
The taxonomy of the Hyaluronidase Market by its scope and segmentation is as follows:
By Type
- Animal-Derived Hyaluronidase
- Synthetic Hyaluronidase
By Application
- Dermatology
- Ophthalmology
- Oncology
- Others
By End-User
- Hospitals
- Specialty Clinics
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
